Who We Are
The team behind a world of change.
Dr. Ross Cagan
Scientific Advisory Board
Regius Chair of Precision Medicine, University of Glasgow. Formerly, Icahn School of Medicine and Director of Center of Personalised Cancer Therapeutics, Mount Sinai, where he developed PDP methodology.
Dr. Marshall Posner
Scientific Advisory Board
Director of the Center for Personalised Cancer Therapeutics at Mount Sinai and Co-Leader of the Cancer Clinical Investigation Program for The Tisch Cancer Institute.
Dr Daniel Krell
Consultant Medical Oncologist
Consultant Medical Oncologist, Royal Free Private, HVA/LOC Harley St, London. Focus on GI cancers and expertise in molecular drivers of cancer.
Michael Elashoff
Scientific Advisory Board
Head of Data Science at Project Ronin. Developed the algorithms behind two validated genomic diagnostic tests (Celmatix, CardioDX).
Prof. Gary Middleton
Medical Advisory Board
Professor of Medical Oncology, Institute of Immunology and Immunotherapy, University pf Birmingham. Gary sits on the Lung CSG, the NCRI advanced colorectal sub-group, the NCRI pancreatic sub-group and CTAAC.
Dr. Elizabeth Smyth
Medical Advisory Board
Clinical Consultant, gastrointestinal oncology, Addenbrooke’s Hospital, Cambridge.
Dr. Jonas Feilchenfeldt
Medical Advisory Board
Consultant in Medical Oncology, core faculty member ESO, Service d’Oncologie Medical, Rivera-Chablis Hospital, Switzerland.
Dr. Michael Castro
Medical Advisory Board
Neuro & Medical Oncologist, Beverly Hills Cancer. Recognised as one of TopDoctors in America by IS News & World Report.
Matthew Scherba
Corporate Advisory Board
Investor and entrepreneur in creating and scaling early stage technology companies across IoT, software, hardware and AI.
Dr Niti Pall
Commercial Advisory Board
Medical Director to KPMG’s Global Health Practice. Senior Advisor to AXA. Formerly Medical and Innovation Director of Emerging Markets for BUPA.
